Clinical Trial: Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism

Brief Summary: Pseudohypoparathyroidism type 1a (PHP1a) is a rare disease that causes childhood obesity and learning difficulties. This study will investigate eating behaviors and perform cognitive testing on children with PHP1a. The investigators will compare their results to those of healthy siblings and other obese children.

Detailed Summary: Pseudohypoparathyroidism type 1a (PHP1a) is a genetic disorder that causes early-onset, syndromic obesity and cognitive impairment. This study aims to evaluate eating behaviors, cognition and executive function in children with PHP1a, compared with healthy siblings and matched obese controls.
Sponsor: Vanderbilt University Medical Center

Current Primary Outcome: Kcals consumed during an ad lib meal [ Time Frame: one day ]

Original Primary Outcome:

  • Kcals consumed during an ad lib meal [ Time Frame: one day ]
  • BRIEF Global Executive Composite Score [ Time Frame: one day ]


Current Secondary Outcome: Intelligence quotient [ Time Frame: one day ]

IQ measured by KBIT


Original Secondary Outcome:

Information By: Vanderbilt University Medical Center

Dates:
Date Received: February 25, 2015
Date Started: December 2014
Date Completion:
Last Updated: January 17, 2017
Last Verified: January 2017